
Loading, please wait...

Loading, please wait...

Researchers have recently developed a novel cascade nanozyme inflammation therapy to address the persistent challenges of reactive oxygen species (ROS) in inflammatory diseases. Chronic inflammation typically leads to high ROS levels. These molecules cause irreversible damage by destroying nucleic acids, proteins, and lipids. Consequently, effectively eliminating excess ROS remains a crucial step in modern medicine. This study introduces a sophisticated platform using ferrihydrite (Fh) and oxidative carbon dots (C-dots) to mimic natural enzyme properties.
The research team synthesized Fh using an innovative copper oxide (CuO)-promoted ferric iron hydrolysis method. This specific approach successfully addressed product sensitivity issues seen in previous manufacturing techniques. Furthermore, the scientists combined these Fh particles with oxidative carbon dot nanozymes through electrostatic and coordination interactions. This process resulted in a stable cascade nanozyme, designated as Fh@C-dot. Additionally, characterization results confirmed that the binding process was highly efficient. Therefore, the composite material retains the unique strengths of both individual components.
During the evaluation, the Fh@C-dot composite demonstrated remarkable catalytic performance. Specifically, Fh exhibited strong catalase (CAT)-like activity. Meanwhile, the C-dots showed excellent superoxide dismutase (SOD)-like activity and hydroxyl radical scavenging capabilities. Moreover, the integrated Fh@C-dot platform possessed both radical scavenging properties and enhanced CAT-like activity. In addition to its chemical efficacy, the platform showed exceptional biosafety. Specifically, in vivo tests on mice confirmed significant therapeutic effects on irritant contact dermatitis. Consequently, this innovation provides a potential alternative to traditional natural antioxidants for treating localized skin inflammation.
The Fh@C-dot nanozyme offers a dual-action approach. It provides both CAT-like and SOD-like activities to scavenge multiple types of reactive oxygen species effectively. Its enhanced radical scavenging ability makes it more potent than individual nanozymes.
The platform targets the oxidative stress at the site of inflammation. By eliminating excess ROS, it prevents cellular damage and reduces the inflammatory response in the skin tissue, as demonstrated in mice models.
Yes, the novel CuO-promoted ferric iron hydrolysis method reduces sensitivity to reaction parameters. This ensures a more consistent and higher quality production of ferrihydrite for medical applications.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed Fh@C-dot, a cascade nanozyme platform that scavenges reactive oxygen species to treat inflammation and irritant contact dermatitis....
6 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday